https://www.selleckchem.com/
ihr, Horvath-Rizea, Hekeler, Ganslandt, Henkes, Hoffmann, Scherlach and Schob.Objectives To assess the imaging biomarkers of glucose metabolic activity and diffusion-weighted imaging (DWI) derived from pretreatment integrated 18F-fluorodeoxyglucose positron emission tomography-magnetic resonance (18F-FDG PET/MR) imaging as potential predictive factors of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Patients and Methods We retrospectively included 17 consecutive patients with pathologically confirmed PDAC by pretreatment 18F-FDG PET/M
Me gusta
Comentario
Compartir
